Viewing Study NCT06730932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-02 @ 8:50 AM
Study NCT ID: NCT06730932
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2024-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
Sponsor: RenJi Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JS004 View
None Toripalimab View
None ccRCC View
None immunotherapy View